blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1448522

EP1448522 - GABUSECTIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND USE OF THE SAME [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.12.2009
Database last updated on 05.10.2024
Most recent event   Tooltip07.10.2011Lapse of the patent in a contracting state
New state(s): CY, TR		published on 09.11.2011  [2011/45]
Applicant(s)For all designated states
Sanofi-Aventis Deutschland GmbH
Brüningstrasse 50
65929 Frankfurt am Main / DE
[N/P]
Former [2005/44]For all designated states
Sanofi-Aventis Deutschland GmbH
Brüningstrasse 50
65929 Frankfurt am Main / DE
Former [2004/35]For all designated states
Aventis Pharma Deutschland GmbH
Brüningstrasse 50
65929 Frankfurt am Main / DE
Inventor(s)01 / SCHIELL, Matthias
Zehntenstrasse 1
65611 Brechen / DE
02 / KNAUF, Martin
Bahnhofstrasse 5, Postfach 331
CH-6037 Root / CH
03 / TOTI, Luigi
Frankfurter Strasse 5
65239 Hochheim / DE
04 / MARKUS-ERB, Astrid
Sulzbacher Strasse 6
65835 Liederbach / DE
 [2004/35]
Application number, filing date02803357.907.11.2002
[2004/35]
WO2002EP12420
Priority number, dateDE200115690621.11.2001         Original published format: DE 10156906
[2004/35]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO03043984
Date:30.05.2003
Language:DE
[2003/22]
Type: A1 Application with search report 
No.:EP1448522
Date:25.08.2004
Language:DE
The application published by WIPO in one of the EPO official languages on 30.05.2003 takes the place of the publication of the European patent application.
[2004/35]
Type: B1 Patent specification 
No.:EP1448522
Date:28.01.2009
Language:DE
[2009/05]
Search report(s)International search report - published on:EP30.05.2003
ClassificationIPC:C07D207/44
[2004/35]
CPC:
C07D207/44 (EP); A61P31/04 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/35]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:GABUSECTIN-DERIVATE, VERFAHREN ZUR DEREN HERSTELLUNG UND DEREN VERWENDUNG[2004/35]
English:GABUSECTIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND USE OF THE SAME[2004/35]
French:DERIVES DE GABUSECTINE, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION[2004/35]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase21.06.2004National basic fee paid 
21.06.2004Designation fee(s) paid 
21.06.2004Examination fee paid 
Examination procedure04.06.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
21.06.2004Examination requested  [2004/35]
18.08.2006Despatch of a communication from the examining division (Time limit: M04)
20.10.2006Reply to a communication from the examining division
01.10.2008Communication of intention to grant the patent
09.12.2008Fee for grant paid
09.12.2008Fee for publishing/printing paid
Opposition(s)29.10.2009No opposition filed within time limit [2010/01]
Fees paidRenewal fee
30.11.2004Renewal fee patent year 03
30.11.2005Renewal fee patent year 04
30.11.2006Renewal fee patent year 05
30.11.2007Renewal fee patent year 06
01.12.2008Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY28.01.2009
CZ28.01.2009
DK28.01.2009
EE28.01.2009
FI28.01.2009
IE28.01.2009
IT28.01.2009
NL28.01.2009
SK28.01.2009
TR28.01.2009
BG28.04.2009
SE28.04.2009
GR29.04.2009
ES09.05.2009
PT29.06.2009
[2011/44]
Former [2011/14]CZ28.01.2009
DK28.01.2009
EE28.01.2009
FI28.01.2009
IE28.01.2009
IT28.01.2009
NL28.01.2009
SK28.01.2009
BG28.04.2009
SE28.04.2009
GR29.04.2009
ES09.05.2009
PT29.06.2009
Former [2010/48]CZ28.01.2009
DK28.01.2009
EE28.01.2009
FI28.01.2009
IE28.01.2009
NL28.01.2009
SK28.01.2009
BG28.04.2009
SE28.04.2009
GR29.04.2009
ES09.05.2009
PT29.06.2009
Former [2010/08]CZ28.01.2009
DK28.01.2009
EE28.01.2009
FI28.01.2009
IE28.01.2009
NL28.01.2009
SK28.01.2009
BG28.04.2009
SE28.04.2009
ES09.05.2009
PT29.06.2009
Former [2009/50]CZ28.01.2009
DK28.01.2009
EE28.01.2009
FI28.01.2009
IE28.01.2009
NL28.01.2009
SK28.01.2009
SE28.04.2009
ES09.05.2009
PT29.06.2009
Former [2009/49]CZ28.01.2009
DK28.01.2009
EE28.01.2009
FI28.01.2009
IE28.01.2009
NL28.01.2009
SE28.04.2009
ES09.05.2009
PT29.06.2009
Former [2009/47]DK28.01.2009
FI28.01.2009
IE28.01.2009
NL28.01.2009
SE28.04.2009
ES09.05.2009
PT29.06.2009
Former [2009/46]DK28.01.2009
FI28.01.2009
NL28.01.2009
SE28.04.2009
ES09.05.2009
PT29.06.2009
Former [2009/38]FI28.01.2009
NL28.01.2009
SE28.04.2009
ES09.05.2009
PT29.06.2009
Former [2009/34]NL28.01.2009
ES09.05.2009
Cited inInternational search[A]WO0174772  (SCHERING CORP [US]) [A] 1-21 * column W *;
 [PA]WO0246152  (AVENTIS PHARMA GMBH [DE]) [PA] 1-21 * column W *;
 [D]DE10060810  (AVENTIS PHARMA GMBH [DE]);
 [A]  - ROYLES B J L, "Naturally Occuring Tetramic Acids: Structure, Isolation, and Synthesis", CHEMICAL REVIEWS, AMERICAN CHEMICAL SOCIETY. EASTON, US, (1995), vol. 95, ISSN 0009-2665, pages 1981 - 2001, XP002206526 [A] 1-21 * figure 11 *

DOI:   http://dx.doi.org/10.1021/cr00038a009
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.